BACKGROUND: Alzheimer's disease and aging brain disorders are progressive, often fatal neurodegenerative diseases. Successful aging, modern lifestyles and behaviors have combined to result in an expected epidemic. Risks for these diseases include genetic, medical, and lifestyle factors; over 20 modifiable risks have been reported. OBJECTIVES: We aim to primarily prevent Alzheimer's disease and related disorders through electronic medical record (EMR)-based screening, risk assessments, interventions, and surveillance. DESIGN: We identified modifiable risks; developed human, systems and infrastructural resources; developed interventions; and targeted at-risk groups for the intervention. SETTING: A Community Based Health System. PARTICIPANTS: In year one (June 2015 to May 2016), 133 at-risk patients received brain health services with the goal of delaying or preventing Alzheimer's disease and related disorders. MEASUREMENTS: We created mechanisms to identify patients at high risk of neurodegenerative disease; EMR-based structured clinical documentation support tools to evaluate risk factors and history; evidence-based interventions to modify risk; and the capacity for annual surveillance, pragmatic trials, and practice-based and genomic research using the EMR. RESULTS: This paper describes our Center for Brain Health, our EMR tools, and our first year of healthy but at-risk patients. CONCLUSION: We are translating research into primary prevention of Alzheimer's disease and related disorders in our health system and aim to shift the paradigm in Neurology from brain disease to brain health.
BACKGROUND:Alzheimer's disease and aging brain disorders are progressive, often fatal neurodegenerative diseases. Successful aging, modern lifestyles and behaviors have combined to result in an expected epidemic. Risks for these diseases include genetic, medical, and lifestyle factors; over 20 modifiable risks have been reported. OBJECTIVES: We aim to primarily prevent Alzheimer's disease and related disorders through electronic medical record (EMR)-based screening, risk assessments, interventions, and surveillance. DESIGN: We identified modifiable risks; developed human, systems and infrastructural resources; developed interventions; and targeted at-risk groups for the intervention. SETTING: A Community Based Health System. PARTICIPANTS: In year one (June 2015 to May 2016), 133 at-risk patients received brain health services with the goal of delaying or preventing Alzheimer's disease and related disorders. MEASUREMENTS: We created mechanisms to identify patients at high risk of neurodegenerative disease; EMR-based structured clinical documentation support tools to evaluate risk factors and history; evidence-based interventions to modify risk; and the capacity for annual surveillance, pragmatic trials, and practice-based and genomic research using the EMR. RESULTS: This paper describes our Center for Brain Health, our EMR tools, and our first year of healthy but at-risk patients. CONCLUSION: We are translating research into primary prevention of Alzheimer's disease and related disorders in our health system and aim to shift the paradigm in Neurology from brain disease to brain health.
Authors: Matthew Baumgart; Heather M Snyder; Maria C Carrillo; Sam Fazio; Hye Kim; Harry Johns Journal: Alzheimers Dement Date: 2015-06-01 Impact factor: 21.566
Authors: Shannon L Risacher; Brenna C McDonald; Eileen F Tallman; John D West; Martin R Farlow; Fredrick W Unverzagt; Sujuan Gao; Malaz Boustani; Paul K Crane; Ronald C Petersen; Clifford R Jack; William J Jagust; Paul S Aisen; Michael W Weiner; Andrew J Saykin Journal: JAMA Neurol Date: 2016-06-01 Impact factor: 18.302
Authors: L S Schneider; F Mangialasche; N Andreasen; H Feldman; E Giacobini; R Jones; V Mantua; P Mecocci; L Pani; B Winblad; M Kivipelto Journal: J Intern Med Date: 2014-03 Impact factor: 8.989
Authors: Joshua W Miller; Danielle J Harvey; Laurel A Beckett; Ralph Green; Sarah Tomaszewski Farias; Bruce R Reed; John M Olichney; Dan M Mungas; Charles DeCarli Journal: JAMA Neurol Date: 2015-11 Impact factor: 18.302
Authors: Andrew S P Lim; Lei Yu; Matthew Kowgier; Julie A Schneider; Aron S Buchman; David A Bennett Journal: JAMA Neurol Date: 2013-12 Impact factor: 18.302
Authors: Martha Clare Morris; John Brockman; Julie A Schneider; Yamin Wang; David A Bennett; Christy C Tangney; Ondine van de Rest Journal: JAMA Date: 2016-02-02 Impact factor: 56.272
Authors: Yi Guo; Qian Li; Xi Yang; Michael S Jaffee; Yonghui Wu; Fei Wang; Jiang Bian Journal: Am J Public Health Date: 2022-03-24 Impact factor: 9.308
Authors: John F Hodes; Carlee I Oakley; James H O'Keefe; Peilin Lu; James E Galvin; Nabeel Saif; Sonia Bellara; Aneela Rahman; Yakir Kaufman; Hollie Hristov; Tarek K Rajji; Anne Marie Fosnacht Morgan; Smita Patel; David A Merrill; Scott Kaiser; Josefina Meléndez-Cabrero; Juan A Melendez; Robert Krikorian; Richard S Isaacson Journal: Front Neurol Date: 2019-01-21 Impact factor: 4.003
Authors: Marwan N Sabbagh; Adriana Perez; Thomas M Holland; Malaz Boustani; Stephanie R Peabody; Kristine Yaffe; Michelle Bruno; Russell Paulsen; Kelly O'Brien; Naila Wahid; Rudolph E Tanzi Journal: Alzheimers Dement Date: 2022-01-13 Impact factor: 16.655